Chlorothiazide Sodium Injection Shortage
Last Updated: August 10, 2021
Status: Resolved
Reason for the Shortage
-
- Akorn had chlorothiazide on allocation due to increased demand.
- American Regent did not provide a reason for the shortage.
- Fresenius Kabi has chlorothiazide injection available.
- Mylan discontinued chlorothiazide injection in May 2020.
- Sagent had chlorothiazide injection on shortage due to manufacturing delays.
- Sun Pharma did not provide a reason for the shortage.
Available Products
-
- Sodium Diuril injection, Akorn, 500 mg, vial, 1 count, NDC 76478-0711-40
- Chlorothiazide injection, Akorn, 500 mg, vial, 1 count, NDC 17478-0419-40
- Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
- Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
- Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
- Chlorothiazide injection, Sun Pharma, 500 mg, vial, 1 count, NDC 47335-0330-40
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated August 10, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.